Serum lipids, lipoproteins and apolipoproteins in adult epileptic patients treated with carbamazepine, valproic acid or phenytoin;Lipidos, lipoproteinas y apolipoproteinas sericas en epilepticos adultos tratados con carbamacepina, acido valproico o fenitoina

Revista de Neurologia

Volumn 27, Issue 159, 1998, Pages 785-789

  Pita Calandre, E ^a,c   Rodriguez Lopez C Ma ^b   Cano, Ma D ^a   Pena Bernal M ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF ALMERÍA   (Spain)

^c Facultad de Medicina   (Spain)

Author keywords

Apolipoproteins; Carbamazepine; Cholesterol; Epilepsy; Lipoproteins; Phenytoin; Val proic acid

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CARBAMAZEPINE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHENYTOIN; TRIACYLGLYCEROL; VALPROIC ACID; ANTICONVULSIVE AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPILEPSY; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; BLOOD; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; ENZYME ACTIVATION; HYPERLIPIDEMIA; MIDDLE AGED; SEXUAL DEVELOPMENT;

ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; APOLIPOPROTEINS; CARBAMAZEPINE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ENZYME ACTIVATION; EPILEPSY; FEMALE; HUMANS; HYPERLIPIDEMIAS; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; PHENYTOIN; SEX CHARACTERISTICS; TRIGLYCERIDES; VALPROIC ACID;

EID: 0032197420     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.27159.98167     Document Type: Article

References (19)

1. Luoma PV, Myllyla VV, Sotaniemi EA, Lehtinen IA, Hokkanen EJ. Plasma high-density lipoprotein cholesterol in epileptics treated with various anticonvulsants. Eur Neurol 1980; 19: 67-72.
2. Luoma PV, Myllyla VV, Hokkanen E. Relationship between plasma high-density lipoprotein cholesterol and anticonvulsant levels in epileptics. J Cardiovasc Pharmacol 1982; 4: 1024-7.
3. Luoma PV, Sotaniemi EA, Arranto AJ. Serum LDL cholesterol, the LDL/HDL cholesterol ratio and liver microsomal enzyme induction evaluated by antipyrine kinetics. Scand J Clin Lab Invest 1983; 43: 671-5.
4. Luoma PV, Sotaniemi EA, Pelkonen RO. Inverse relationship of serum LDL cholesterol and the LDL/HDL cholesterol ratio to liver microsomal enzyme induction in man. Res Commun Chem Pathol Pharmacol 1983; 42: 173-6.
5. Luoma PV, Sotaniemi EA, Pelkonen RO, Pirttiaho HI. Serum low-density lipoprotein and high-density lipoprotein cholesterol, and liver size in subjects on drugs inducing hepatic microsomal enzymes. Eur J Clin Pharmacol 1985; 28: 615-8
6. Berlit P, Krause KH, Heuck CC, Schellenberg B. Serum lipids and anticonvulsants. Acta Neurol Scand 1982; 66: 328-33.
7. Reddy MN. Effect on anticonvulsant drugs on plasma total cholesterol, high-density lipoprotein cholesterol, and apolipoproteins A and B in children with epilepsy. Proc Soc Exp Biol Med 1985; 180: 359-63.
8. Franzoni E, Govoni M, D'Addato S, Gualandi S, Sangiorgi Z, Descovich GC, et al. Total cholesterol, high-density lipoprotein cholesterol, and triglycerides in children receiving antiepileptic drugs. Epilepsia 1992; 33: 932-5.
9. Isojärvi JIT, Pakarinen AJ, Myllylä VV. Serum lipid levels during carbamazepine medication. A prospective study. Arch Neurol 1993; 50: 590-3.
10. Eirís JM, Lojo S, del Rio MC, Novo I, Bravo M, Pavón P, et al. Effects of long-term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy. Neurology 1995; 45: 1155-7.
11. De Juan Frigola J, Crespo Hernández M, Braga Hernández S. Efectos del fenobarbital, ácido valproico y carbamazepina sobre lipidos y lipoproteínas séricas en una población infanto-juvenil. An Esp Pediatr 1996; 44: 133-8.
12. Sozuer D, Atakil D, Dogu O, Baybas S, Arpaci B. Serum lipids in epileptic children treated with carbamazepine and valproate. Eur J Pediatr 1997; 156: 565-7.
13. Verrotti A, Domizio S, Angelozzi B, Sabatino G, Morgese G, Chiarelli F. Changes in serum lipids and lipoproteins in epileptic children treated with anticonvulsants. J Paediatr Child Health 1997; 33: 242-5.
14. Heldenberg D, Harel S, Holtzman M, Levtow O, Tamir I. The effect of chronic anticonvulsant therapy on serum lipids and lipoproteins in epileptic children. Neurology 1983; 33: 510-3.
15. Calandre EP, Rodríguez-López C, Blázquez A, Cano D. Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital. Acta Neurol Scand 1991; 83: 250-3.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
17. Laurel CB. Electroimmunoassay. Scand J Clin Lab Invest 1972; 29 (Suppl 124): S21-37.
18. Luoma PV, Rautio A, Stengard J, Sotaniemi EA, Marniemi J. High-density lipoprotein subfractions apolipoproteins and antipyrine clearance in normal subjects. Eur J Clin Pharmacol 1990; 38: 625-7.
19. Pita Calandre E, Sinués Porta B, García de la Calzada D. The effect of chronic phenytoin treatment on serum lipid profile in adult epileptic patients. Epilepsia 1992; 33: 154-7.